Table 3 Survival analysis at 6, 12 months, and overall
Palliative | TES | |
|---|---|---|
Survival at 6 months | 22 | 22 |
Time at risk: person-months | 156.9 | 289.83 |
Incidence rate per 100 (95%CI) | 8.92 (5.28–15.07) | 1.73 (0.72–4.14) |
Mean survival time (95%CI), months | 14.85 (7.84–21.85) | 34.59 (26.90–42.28) |
Survival probability | ||
At 2 mo. (95%CI) | 63.64% (40.29–79.88) | 86.12% (62.86–95.31) |
At 4 mo. (95%CI) | 45.45% (24.44–64.33) | 76.56% (52.49–89.52) |
At 6 mo. (95%CI) | 36.36% (17.43–55.67) | 76.56% (52.49–89.52) |
Survival at 12 months | ||
Time at risk: person-months | 156.9 | 289.83 |
Incidence rate per 100 (95%CI) | 9.56 (5.76–15.86) | 2.42 (1.15–5.07) |
Mean survival time (95%CI), months | 13.53 (6.80–20.26) | 30.92 (22.57–39.28) |
Survival probability | ||
At 3 mo. (95%CI) | 54.55% (32.07–72.39) | 77.27% (53.74–89.85) |
At 6 mo. (95%CI) | 36.36% (17.43–55.67) | 72.73% (49.10–86.71) |
At 9 mo. (95%CI) | 31.82% (14.18–51.11) | 67.13% (42.90–82.89) |
At 12 mo. (95%CI) | 31.82% (14.18–51.11) | 67.13% (42.90–82.89) |
Overall Survival | ||
Time at risk: person-months | 156.9 | 289.83 |
Incidence rate per 100 (95%CI) | 11.47 (7.23–18.21) | 5.52 (3.38–9.01) |
Median survival time (95%CI), months | 3.13 (0.64–5.62) | 9.97 (6.14–13.80) |
Survival probability | ||
At 5 mo. (95%CI) | 40.91% (20.85–60.07) | 72.73% (49.10–86.71) |
At 10 mo. (95%CI) | 27.27% (11.12–46.37) | 50.00% (28.18–68.43) |
At 15 mo. (95%CI) | 16.36% (4.39–35.06) | 40.91% (20.85–60.07) |
At 20 mo. (95%CI) | 16.36% (4.39–35.06) | 36.36% (17.43–55.67) |
At 25 mo. (95%CI) | 16.36% (4.39–35.06) | 29.09% (11.23–49.79) |
At 30 mo. (95%CI) | 16.36% (4.39–35.06) | 14.55% (1.33–42.29) |
At 35 mo. (95%CI) | 16.36% (4.39–35.06) | 14.55% (1.33–42.29) |
At 40 mo. (95%CI) | - | 14.55% (1.33–42.29) |